Effects of bacillus subtilis on epithelial tight junctions of mice with inflammatory bowel disease

Journal of Interferon and Cytokine Research

Volumn 36, Issue 2, 2016, Pages 75-85

  Gong, Yi ^a   Li, Hui ^a   Li, Yan ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOSALICYLIC ACID; BETA ACTIN; CLAUDIN 1; INTERLEUKIN 17; INTERLEUKIN 23; INTERLEUKIN 6; JUNCTIONAL ADHESION MOLECULE A; OCCLUDIN; PROBIOTIC AGENT; PROTEIN ZO1; TAP WATER; TUMOR NECROSIS FACTOR ALPHA; BIOLOGICAL MARKER; TIGHT JUNCTION PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACILLUS SUBTILIS; BODY WEIGHT; CELL INFILTRATION; CONTROLLED STUDY; DEFECATION; DEXTRAN SODIUM SULFATE-INDUCED COLITIS; DISEASE ACTIVITY; DOWN REGULATION; FEMALE; HISTOLOGY; IMMUNOHISTOCHEMISTRY; INTESTINE EPITHELIUM; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; TIGHT JUNCTION; UPREGULATION; WESTERN BLOTTING; ANIMAL; DIAGNOSTIC IMAGING; DISEASE MODEL; GENETICS; INFLAMMATORY BOWEL DISEASES; INTESTINE MUCOSA; METABOLISM; MICROBIOLOGY; PATHOLOGY; PHYSIOLOGY; SEVERITY OF ILLNESS INDEX; ULTRASTRUCTURE; WEIGHT REDUCTION;

ANIMALS; BACILLUS SUBTILIS; BIOMARKERS; DISEASE MODELS, ANIMAL; FEMALE; IMMUNOHISTOCHEMISTRY; INFLAMMATORY BOWEL DISEASES; INTESTINAL MUCOSA; MALE; MICE; SEVERITY OF ILLNESS INDEX; TIGHT JUNCTION PROTEINS; TIGHT JUNCTIONS; WEIGHT LOSS;

EID: 84957629270     PISSN: 10799907     EISSN: 15577465     Source Type: Journal    
DOI: 10.1089/jir.2015.0030     Document Type: Article

References (41)

1. Agostoni C, Axelsson I, Braegger C, Goulet O, Koletzko B, Michaelsen KF, Rigo J, Shamir R, Szajewska H, Turck D, Weaver LT. (2004). Probiotic bacteria in dietetic products for infants: a commentary by the ESPGHAN Committee on Nutrition. J Pediatr Gastroenterol Nutr 38(4): 365-374
2. Al-Sadi R, Guo S, Dokladny K, Smith MA, Ye D, Kaza A, Watterson DM, Ma TY. (2012). Mechanism of interleukin-1beta induced-increase in mouse intestinal permeability in vivo. J Interferon Cytokine Res 32(10): 474-484
3. Amasheh M, Grotjohann I, Amasheh S, Fromm A, Soderholm JD, Zeitz M, Fromm M, Schulzke JD. (2009). Regulation of mucosal structure and barrier function in rat colon exposed to tumor necrosis factor alpha and interferon gamma in vitro: a novel model for studying the pathomechanisms of inflammatory bowel disease cytokines. Scand J Gastroenterol 44(10): 1226-1235
4. Atreya R, Neurath MF. (2005). Involvement of IL-6 in the pathogenesis of inflammatory bowel disease and colon cancer. Clin Rev Allergy Immunol 28(3): 187-196
5. Bazzoni G. (2011). Pathobiology of junctional adhesion molecules. Antioxid Redox Signal 15(5): 1221-1234
6. Bettelli E, Carrier Y, Gao W, Korn T, Strom TB, Oukka M, Weiner HL, Kuchroo VK. (2006). Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 441(7090): 235-238
7. Bradfield PF, Nourshargh S, Aurrand-Lions M, Imhof BA. (2007). JAM family and related proteins in leukocyte migration (Vestweber series). Arterioscler Thromb Vasc Biol 27(10): 2104-2112
8. Capaldo CT, Nusrat A. (2009). Cytokine regulation of tight junctions. Biochim Biophys Acta 1788(4): 864-871
9. Chiba H, Kojima T, Osanai M, Sawada N. (2006). The significance of interferon-gamma-triggered internalization of tightjunction proteins in inflammatory bowel disease. Sci STKE 2006(316): pe1
10. Das P, Goswami P, Das TK, Nag T, Sreenivas V, Ahuja V, Panda SK, Gupta SD, Makharia GK. (2012). Comparative tight junction protein expressions in colonic Crohn's disease, ulcerative colitis, and tuberculosis: a new perspective. Virchows Arch 460(3): 261-270
11. Du D, Xu F, Yu L, Zhang C, Lu X, Yuan H, Huang Q, Zhang F, Bao H, Jia L, Wu X, Zhu X, Zhang X, Zhang Z, Chen Z. (2010). The tight junction protein, occludin, regulates the directional migration of epithelial cells. Dev Cell 18(1): 52-63
12. Gaffen SL. (2008). An overview of IL-17 function and signaling. Cytokine 43(3): 402-407
13. Gao Q, Qi L, Wu T, Wang J. (2012). An important role of interleukin-10 in counteracting excessive immune response in HT-29 cells exposed to Clostridium butyricum. BMC Microbiol 12: 100
14. Harrington LE, Hatton RD, Mangan PR, Turner H, Murphy TL, Murphy KM, Weaver CT. (2005). Interleukin 17-producing CD4 + effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol 6(11): 1123-1132
15. Heller F, Florian P, Bojarski C, Richter J, Christ M, Hillenbrand B, Mankertz J, Gitter AH, Burgel N, Fromm M, Zeitz M, Fuss I, Strober W, Schulzke JD. (2005). Interleukin-13 is the key effector Th2 cytokine in ulcerative colitis that affects epithelial tight junctions, apoptosis, and cell restitution. Gastroenterology 129(2): 550-564
16. Ivanov AI, Nusrat A, Parkos CA. (2004). The epithelium in inflammatory bowel disease: potential role of endocytosis of junctional proteins in barrier disruption. Novartis Found Symp 263: 115-124; discussion 124-132, 211-218
17. Iwakura Y, Ishigame H. (2006). The IL-23/IL-17 axis in inflammation. J Clin Invest 116(5): 1218-1222
18. John LJ, Fromm M, Schulzke JD. (2011). Epithelial barriers in intestinal inflammation. Antioxid Redox Signal 15(5): 1255-1270
19. Kalliomäki MA, Walker WA. (2005). Physiologic and pathologic interactions of bacteria with gastrointestinal epithelium. Gastroenterol Clin North Am 34(3): 383-399
20. Kelly D, Mulder IE. (2012). Microbiome and immunological interactions. Nutr Rev 70(Suppl 1): S18-S30
21. Kucharzik T, Walsh SV, Chen J, Parkos CA, Nusrat A. (2001). Neutrophil transmigration in inflammatory bowel disease is associated with differential expression of epithelial intercellular junction proteins. Am J Pathol 159(6): 2001-2009
22. Lakatos PL. (2006). Recent trends in the epidemiology of inflammatory bowel diseases: up or down? World J Gastroenterol 12(38): 6102-6108
23. Lal-Nag M, Morin PJ. (2009). The claudins. Genome Biol 10(8): 235
24. Licciardi PV, Wong SS, Tang ML, Karagiannis TC. (2010). Epigenome targeting by probiotic metabolites. Gut Pathog 2(1): 24
25. Lu L, Walker WA. (2001). Pathologic and physiologic interactions of bacteria with the gastrointestinal epithelium. Am J Clin Nutr 73(6): 1124S-1130S
26. Ma TY, Iwamoto GK, Hoa NT, Akotia V, Pedram A, Boivin MA, Said HM. (2004). TNF-alpha-induced increase in intestinal epithelial tight junction permeability requires NF-kappa B activation. Am J Physiol Gastrointest Liver Physiol 286(3): G367-G376
27. Maione F, Paschalidis N, Mascolo N, Dufton N, Perretti M, D'Acquisto F. (2009). Interleukin 17 sustains rather than induces inflammation. Biochem Pharmacol 77(5): 878-887
28. Markov AG, Veshnyakova A, Fromm M, Amasheh M, Amasheh S. (2010). Segmental expression of claudin proteins correlates with tight junction barrier properties in rat intestine. J Comp Physiol B 180(4): 591-598
29. Monteiro AC, Parkos CA. (2012). Intracellular mediators of JAM-A-dependent epithelial barrier function. Ann N Y Acad Sci 1257: 115-124
30. Nishikawa J, Kudo T, Sakata S, Benno Y, Sugiyama T. (2009). Diversity of mucosa-associated microbiota in active and inactive ulcerative colitis. Scand J Gastroenterol 44(2): 180-186
31. Park H, Li Z, Yang XO, Chang SH, Nurieva R, Wang YH, Wang Y, Hood L, Zhu Z, Tian Q, Dong C. (2005). A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat Immunol 6(11): 1133-1141
32. Poritz LS, Garver KI, Green C, Fitzpatrick L, Ruggiero F, Koltun WA. (2007). Loss of the tight junction protein ZO-1 in dextran sulfate sodium induced colitis. J Surg Res 140(1): 12-19
33. Poritz LS, Harris LR, 3rd, Kelly AA, Koltun WA. (2011). Increase in the tight junction protein claudin-1 in intestinal inflammation. Dig Dis Sci 56(10): 2802-2809
34. Raddatz D, Bockemuhl M, Ramadori G. (2005). Quantitative measurement of cytokine mRNA in inflammatory bowel disease: relation to clinical and endoscopic activity and outcome. Eur J Gastroenterol Hepatol 17(5): 547-557
35. Selvam R, Maheswari P, Kavitha P, Ravichandran M, Sas B, Ramchand CN. (2009). Effect of Bacillus subtilis PB6, a natural probiotic on colon mucosal inflammation and plasma cytokines levels in inflammatory bowel disease. Indian J Biochem Biophys 46(1): 79-85
36. Severson EA, Parkos CA. (2009). Structural determinants of Junctional Adhesion Molecule A (JAM-A) function and mechanisms of intracellular signaling. Curr Opin Cell Biol 21(5): 701-707
37. Song X, Qian Y. (2013). The activation and regulation of IL-17 receptor mediated signaling. Cytokine 62(2): 175-182
38. Ueno A, Jijon H, Chan R, Ford K, Hirota C, Kaplan GG, Beck PL, Iacucci M, Fort Gasia M, Barkema HW, Panaccione R, Ghosh S. (2013). Increased prevalence of circulating novel IL-17 secreting Foxp3 expressing CD4 + T cells and defective suppressive function of circulating Foxp3 + regulatory cells support plasticity between Th17 and regulatory T cells in inflammatory bowel disease patients. Inflamm Bowel Dis 19(12): 2522-2534
39. Vetrano S, Rescigno M, Cera MR, Correale C, Rumio C, Doni A, Fantini M, Sturm A, Borroni E, Repici A, Locati M, Malesci A, Dejana E, Danese S. (2008). Unique role of junctional adhesion molecule-a in maintaining mucosal homeostasis in inflammatory bowel disease. Gastroenterology 135(1): 173-184
40. Ye D, Ma I, Ma TY. (2006). Molecular mechanism of tumor necrosis factor-alpha modulation of intestinal epithelial tight junction barrier. Am J Physiol Gastrointest Liver Physiol 290(3): G496-G504
41. Zeissig S, Burgel N, Gunzel D, Richter J, Mankertz J, Wahnschaffe U, Kroesen AJ, Zeitz M, Fromm M, Schulzke JD. (2007). Changes in expression and distribution of claudin 2, 5 and 8 lead to discontinuous tight junctions and barrier dysfunction in active Crohn's disease. Gut 56(1): 61-72